Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Dare Bioscience (DARE) EPS (Basic) (2016 - 2025)

Dare Bioscience (DARE) has disclosed EPS (Basic) for 11 consecutive years, with -$0.23 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EPS (Basic) rose 58.93% year-over-year to -$0.23, compared with a TTM value of -$1.83 through Sep 2025, up 50.41%, and an annual FY2024 reading of -$0.48, up 88.43% over the prior year.
  • EPS (Basic) was -$0.23 for Q3 2025 at Dare Bioscience, up from -$0.45 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $1.54 in Q2 2024 and bottomed at -$3.86 in Q4 2023.
  • Average EPS (Basic) over 5 years is -$0.52, with a median of -$0.19 recorded in 2022.
  • The sharpest move saw EPS (Basic) tumbled 49236.55% in 2023, then surged 169.06% in 2024.
  • Year by year, EPS (Basic) stood at -$0.11 in 2021, then tumbled by 72.73% to -$0.19 in 2022, then tumbled by 1931.58% to -$3.86 in 2023, then skyrocketed by 83.16% to -$0.65 in 2024, then skyrocketed by 64.62% to -$0.23 in 2025.
  • Business Quant data shows EPS (Basic) for DARE at -$0.23 in Q3 2025, -$0.45 in Q2 2025, and -$0.5 in Q1 2025.